OpenURL Connection Search

Select item for more details and to access through your institution.

Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia.
Published in:
Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1340, doi. 10.1177/10781552211024727
By:
- Zacholski, Kyle;
- Hambley, Bryan;
- Hickey, Erin;
- Kashanian, Sarah;
- Li, Andrew;
- Baer, Maria R;
- Duong, Vu H;
- Newman, Matthew J;
- DeZern, Amy;
- Gojo, Ivana;
- Smith, B Douglas;
- Levis, Mark J;
- Varadhan, Ravi;
- Gehrie, Eric;
- Emadi, Ashkan;
- Ghiaur, Gabriel
Publication type:
Article
Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant Pharmacogenes.
Published in:
Cancers, 2021, v. 13, n. 18, p. 4524, doi. 10.3390/cancers13184524
By:
- Hutchcraft, Megan L.;
- Lin, Nan;
- Zhang, Shulin;
- Sears, Catherine;
- Zacholski, Kyle;
- Belcher, Elizabeth A.;
- Durbin, Eric B.;
- Villano, John L.;
- Cavnar, Michael J.;
- Arnold, Susanne M.;
- Ueland, Frederick R.;
- Kolesar, Jill M.
Publication type:
Article
FLT3 -ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification.
Published in:
Biology (2079-7737), 2021, v. 10, n. 3, p. 243, doi. 10.3390/biology10030243
By:
- Li, Andrew Y.;
- Kashanian, Sarah M.;
- Hambley, Bryan C.;
- Zacholski, Kyle;
- Duong, Vu H.;
- El Chaer, Firas;
- Holtzman, Noa G.;
- Gojo, Ivana;
- Webster, Jonathan A.;
- Norsworthy, Kelly J.;
- Smith, Bruce Douglas;
- DeZern, Amy E.;
- Levis, Mark J.;
- Baer, Maria R.;
- Kamangar, Farin;
- Ghiaur, Gabriel;
- Emadi, Ashkan
Publication type:
Article
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia.
Published in:
International Journal of Hematology, 2023, v. 118, n. 6, p. 682, doi. 10.1007/s12185-023-03670-3
By:
- Shinn, Lauren T.;
- Benitez, Lydia L.;
- Perissinotti, Anthony J.;
- Reid, Justin H.;
- Buhlinger, Kaitlyn M.;
- van Deventer, Hendrik;
- Barth, Dylan;
- Wagner, Charlotte B.;
- Zacholski, Kyle;
- Desai, Ruchi;
- Soule, Ashley;
- Stump, Sarah E.;
- Weis, Taylor M.;
- Bixby, Dale;
- Burke, Patrick;
- Pettit, Kristen;
- Marini, Bernard L.
Publication type:
Article
Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia.
Published in:
EJHaem, 2023, v. 4, n. 2, p. 381, doi. 10.1002/jha2.663
By:
- Bouligny, Ian M.;
- Murray, Graeme;
- Doyel, Michael;
- Patel, Tilak;
- Boron, Josh;
- Tran, Valerie;
- Gor, Juhi;
- Hang, Yiwei;
- Alnimer, Yanal;
- Zacholski, Kyle;
- Venn, Chad;
- Wages, Nolan A.;
- Grant, Steven;
- Maher, Keri R.
Publication type:
Article
Increased body mass index is a risk factor for acute promyelocytic leukemia.
Published in:
EJHaem, 2021, v. 2, n. 1, p. 33, doi. 10.1002/jha2.163
By:
- Kashanian, Sarah M.;
- Li, Andrew Y.;
- Ali, Moaath Mustafa;
- Sutherland, Mark E.;
- Duong, Vu H.;
- Hambley, Bryan C.;
- Zacholski, Kyle;
- El Chaer, Firas;
- Holtzman, Noa G.;
- Imran, Mohammad;
- Patzke, Ciera L.;
- Cornu, Jonathan;
- Duffy, Alison;
- Dezern, Amy E.;
- Gojo, Ivana;
- Norsworthy, Kelly J.;
- Levis, Mark J.;
- Smith, B. Douglas;
- Baer, Maria R.;
- Ghiaur, Gabriel
Publication type:
Article
Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia.
Published in:
Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-024-02302-y
By:
- Bouligny, Ian M.;
- Murray, Graeme;
- Doyel, Michael;
- Patel, Tilak;
- Boron, Josh;
- Tran, Valerie;
- Gor, Juhi;
- Hang, Yiwei;
- Alnimer, Yanal;
- Ho, Thuy;
- Zacholski, Kyle;
- Venn, Chad;
- Wages, Nolan A.;
- Grant, Steven;
- Maher, Keri R.
Publication type:
Article

Found: 7

Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia.

Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant Pharmacogenes.

FLT3 -ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification.

Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia.

Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia.

Increased body mass index is a risk factor for acute promyelocytic leukemia.

Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia.